Discontinuation Leads News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<p>The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year. At the same time, the study shows that remaining on the drug not only promotes additional weight loss but preserves improvements in metabolic and cardiovascular health.</p>
....

United States , Louis Aronne , Eli Lilly , Presbyterian Weill Cornell Medical Center , Weight Control Center , Drug Administration , Sanfordi Weill Professor Of Metabolic Research , Division Of Endocrinology , Tirzepatide Enhances Weight Loss , Sustained Treatment , Discontinuation Leads , Weill Cornell Medicine , Metabolic Research , Comprehensive Weight Control Center , Weill Cornell , Weill Cornell Medical , Mimics Natural Hormones , Foster Feeling ,